Tapewire

OTC · USD

EMMA

Emmaus Life Sciences, Inc.

Export transactions ↓
Tapewire entity
205
SEC CIK
0000822370
Parsed reports
310

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202640
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 30, 2022 Filed Dec 1, 2022 18:35 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 22,900 $0.41 $9,389.00
Disclosure

SEC source: 0001209191-22-059154 · doc4.xml · nonDerivative · entry 5

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,040,857

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.40 to $0.44, inclusive.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
November 29, 2022 Filed Dec 1, 2022 18:35 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 14,700 $0.38 $5,586.00
Disclosure

SEC source: 0001209191-22-059154 · doc4.xml · nonDerivative · entry 4

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,017,957

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.36 to $0.40, inclusive.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
November 28, 2022 Filed Dec 1, 2022 18:35 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 5,000 $0.35 $1,750.00
Disclosure

SEC source: 0001209191-22-059154 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,003,257

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
November 04, 2022 Filed Dec 1, 2022 18:35 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 7,500 $0.45 $3,375.00
Disclosure

SEC source: 0001209191-22-059154 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,998,257

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.45 to $0.46, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnotes (3) and (4) to this Form 4.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
November 03, 2022 Filed Dec 1, 2022 18:35 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,500 $0.45 $1,125.00
Disclosure

SEC source: 0001209191-22-059154 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,990,757

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
November 02, 2022 Filed Nov 3, 2022 18:50 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 15,000 $0.43 $6,450.00
Disclosure

SEC source: 0001209191-22-055471 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,988,257

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.42 to $0.45, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
November 01, 2022 Filed Nov 3, 2022 18:50 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 5,000 $0.43 $2,150.00
Disclosure

SEC source: 0001209191-22-055471 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,973,257

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.42 to $0.44, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 31, 2022 Filed Nov 3, 2022 18:50 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 7,500 $0.45 $3,375.00
Disclosure

SEC source: 0001209191-22-055471 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,968,257

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.44 to $0.46, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 28, 2022 Filed Oct 31, 2022 18:59 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 7,500 $0.42 $3,150.00
Disclosure

SEC source: 0001209191-22-054902 · doc4.xml · nonDerivative · entry 5

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,960,757

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.40 to $0.47, inclusive.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 27, 2022 Filed Oct 31, 2022 18:59 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 22,500 $0.27 $6,075.00
Disclosure

SEC source: 0001209191-22-054902 · doc4.xml · nonDerivative · entry 4

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,953,257

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.26 to $0.35, inclusive.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 26, 2022 Filed Oct 31, 2022 18:59 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 11,900 $0.27 $3,213.00
Disclosure

SEC source: 0001209191-22-054902 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,930,757

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.25 to $0.35, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnotes (3) and (4) to this Form 4.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 25, 2022 Filed Oct 31, 2022 18:59 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 20,000 $0.26 $5,200.00
Disclosure

SEC source: 0001209191-22-054902 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,918,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 24, 2022 Filed Oct 31, 2022 18:59 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 7,500 $0.22 $1,650.00
Disclosure

SEC source: 0001209191-22-054902 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,898,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 21, 2022 Filed Oct 24, 2022 22:34 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 10,000 $0.19 $1,900.00
Disclosure

SEC source: 0001209191-22-054449 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,891,357

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 20, 2022 Filed Oct 24, 2022 22:34 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 30,000 $0.18 $5,400.00
Disclosure

SEC source: 0001209191-22-054449 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,881,357

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.17 to $0.21, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 19, 2022 Filed Oct 24, 2022 22:34 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 25,000 $0.16 $4,000.00
Disclosure

SEC source: 0001209191-22-054449 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,851,357

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.15 to $0.20, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 18, 2022 Filed Oct 19, 2022 18:21 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 30,000 $0.19 $5,700.00
Disclosure

SEC source: 0001209191-22-054051 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,826,357

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.17 to $0.20, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 17, 2022 Filed Oct 19, 2022 18:21 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 15,000 $0.20 $3,000.00
Disclosure

SEC source: 0001209191-22-054051 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,796,357

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.20 to $0.22, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 14, 2022 Filed Oct 17, 2022 17:01 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 35,000 $0.17 $5,950.00
Disclosure

SEC source: 0001209191-22-053757 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,781,357

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.15 to $0.18, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 13, 2022 Filed Oct 17, 2022 17:01 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 62,500 $0.18 $11,250.00
Disclosure

SEC source: 0001209191-22-053757 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,746,357

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.10 to $0.31, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 12, 2022 Filed Oct 13, 2022 20:05 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 160,000 $0.08 $12,800.00
Disclosure

SEC source: 0001209191-22-053559 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,683,857

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.07 to $0.09, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 11, 2022 Filed Oct 12, 2022 17:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 130,000 $0.09 $11,700.00
Disclosure

SEC source: 0001209191-22-053433 · doc4.xml · nonDerivative · entry 9

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,518,857

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.08 to $0.12, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 11, 2022 Filed Oct 13, 2022 20:05 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 5,000 $0.09 $450.00
Disclosure

SEC source: 0001209191-22-053559 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,523,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 10, 2022 Filed Oct 12, 2022 17:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 10,000 $0.09 $900.00
Disclosure

SEC source: 0001209191-22-053433 · doc4.xml · nonDerivative · entry 8

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,388,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 09, 2022 Filed Dec 20, 2023 00:44 UTC
Lim Seah H.Director
PurchaseCommon stock, $0.001 par value 25,400 $0.11 $2,794.00
Disclosure

SEC source: 0001209191-23-059268 · doc4.xml · nonDerivative · entry 1

Lim Seah H. · CIK 0001949484 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,900

Read SEC document
October 07, 2022 Filed Oct 12, 2022 17:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 4,000 $0.13 $520.00
Disclosure

SEC source: 0001209191-22-053433 · doc4.xml · nonDerivative · entry 7

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,378,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 06, 2022 Filed Oct 12, 2022 17:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 5,000 $0.15 $750.00
Disclosure

SEC source: 0001209191-22-053433 · doc4.xml · nonDerivative · entry 6

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,374,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 05, 2022 Filed Oct 12, 2022 17:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 10,000 $0.15 $1,500.00
Disclosure

SEC source: 0001209191-22-053433 · doc4.xml · nonDerivative · entry 5

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,369,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 04, 2022 Filed Oct 12, 2022 17:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 5,000 $0.16 $800.00
Disclosure

SEC source: 0001209191-22-053433 · doc4.xml · nonDerivative · entry 4

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,359,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
October 03, 2022 Filed Oct 12, 2022 17:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 10,000 $0.20 $2,000.00
Disclosure

SEC source: 0001209191-22-053433 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,354,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
September 27, 2022 Filed Oct 12, 2022 17:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 5,000 $0.20 $1,000.00
Disclosure

SEC source: 0001209191-22-053433 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,344,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
September 26, 2022 Filed Oct 12, 2022 17:04 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 6,000 $0.20 $1,200.00
Disclosure

SEC source: 0001209191-22-053433 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,339,857

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
September 20, 2022 Filed Jun 2, 2023 17:23 UTC
LEE WILLIS CDirector · COO
PurchaseCommon stock, $0.001 par value 750 $0.28 $210.00
Disclosure

SEC source: 0001209191-23-033573 · doc4.xml · nonDerivative · entry 1

LEE WILLIS C · CIK 0001517775 · Director · COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,724

Read SEC document
July 19, 2022 Filed Jul 25, 2022 16:49 UTC
LEE WILLIS CDirector · COO
PurchaseCommon stock, $0.001 par value 3,200 $0.39 $1,248.00
Disclosure

SEC source: 0001209191-22-043081 · doc4.xml · nonDerivative · entry 1

LEE WILLIS C · CIK 0001517775 · Director · COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,974

Read SEC document
May 31, 2022 Filed Jun 3, 2022 15:52 UTC
LEE WILLIS CDirector · Director & COO
PurchaseCommon stock, $0.001 par value 2,500 $0.40 $1,000.00
Disclosure

SEC source: 0001209191-22-033847 · doc4.xml · nonDerivative · entry 2

LEE WILLIS C · CIK 0001517775 · Director · Director & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,774

Read SEC document
May 27, 2022 Filed Jun 3, 2022 15:52 UTC
LEE WILLIS CDirector · Director & COO
PurchaseCommon stock, $0.001 par value 2,500 $0.37 $925.00
Disclosure

SEC source: 0001209191-22-033847 · doc4.xml · nonDerivative · entry 1

LEE WILLIS C · CIK 0001517775 · Director · Director & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,274

Read SEC document
May 23, 2022 Filed Jun 2, 2022 23:49 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 2,000 $0.50 $1,000.00
Disclosure

SEC source: 0001209191-22-033730 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,333,857

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
May 20, 2022 Filed Jun 2, 2022 23:49 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 5,000 $0.49 $2,450.00
Disclosure

SEC source: 0001209191-22-033730 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,331,857

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.48 to $0.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
May 18, 2022 Filed May 19, 2022 18:45 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 7,351 $0.35 $2,572.85
Disclosure

SEC source: 0001209191-22-030451 · doc4.xml · nonDerivative · entry 3

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,326,857

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.28 to $0.40, inclusive.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
May 13, 2022 Filed May 19, 2022 18:45 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 10,000 $0.34 $3,400.00
Disclosure

SEC source: 0001209191-22-030451 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,319,506

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.33 to $0.35, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnote (3) to this Form 4.

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
May 09, 2022 Filed May 19, 2022 18:45 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 6,000 $0.60 $3,600.00
Disclosure

SEC source: 0001209191-22-030451 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,309,506

F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
April 11, 2022 Filed Apr 12, 2022 19:59 UTC
LEE WILLIS CDirector · Director & COO
PurchaseCommon stock, $0.001 par value 8,900 $0.88 $7,832.00
Disclosure

SEC source: 0001209191-22-024129 · doc4.xml · nonDerivative · entry 4

LEE WILLIS C · CIK 0001517775 · Director · Director & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278,774

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.85 to $0.89, inclusive.

Read SEC document
April 08, 2022 Filed Apr 12, 2022 19:59 UTC
LEE WILLIS CDirector · Director & COO
PurchaseCommon stock, $0.001 par value 1,600 $0.76 $1,216.00
Disclosure

SEC source: 0001209191-22-024129 · doc4.xml · nonDerivative · entry 3

LEE WILLIS C · CIK 0001517775 · Director · Director & COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee

Disclosed balance after: 241,194

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.75 to $0.78, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4.

Read SEC document
April 06, 2022 Filed Apr 12, 2022 19:59 UTC
LEE WILLIS CDirector · Director & COO
PurchaseCommon stock, $0.001 par value 1,400 $0.95 $1,330.00
Disclosure

SEC source: 0001209191-22-024129 · doc4.xml · nonDerivative · entry 2

LEE WILLIS C · CIK 0001517775 · Director · Director & COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee

Disclosed balance after: 239,594

Read SEC document
April 04, 2022 Filed Apr 12, 2022 19:59 UTC
LEE WILLIS CDirector · Director & COO
PurchaseCommon stock, $0.001 par value 3,200 $0.98 $3,136.00
Disclosure

SEC source: 0001209191-22-024129 · doc4.xml · nonDerivative · entry 1

LEE WILLIS C · CIK 0001517775 · Director · Director & COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee

Disclosed balance after: 238,194

Read SEC document
February 28, 2022 Filed Feb 28, 2022 22:34 UTC
LEE WILLIS CDirector · Vice Chairman & COO
PurchaseCommon stock, $0.001 par value 900 $1.65 $1,485.00
Disclosure

SEC source: 0001209191-22-013725 · doc4.xml · nonDerivative · entry 5

LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee

Disclosed balance after: 1,900

Read SEC document
February 28, 2022 Filed Feb 28, 2022 22:34 UTC
LEE WILLIS CDirector · Vice Chairman & COO
PurchaseCommon stock, $0.001 par value 6,600 $1.50 $9,900.00
Disclosure

SEC source: 0001209191-22-013725 · doc4.xml · nonDerivative · entry 4

LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee

Disclosed balance after: 234,994

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.60, inclusive.

Read SEC document
February 28, 2022 Filed Feb 28, 2022 22:34 UTC
LEE WILLIS CDirector · Vice Chairman & COO
PurchaseCommon stock, $0.001 par value 7,200 $1.51 $10,872.00
Disclosure

SEC source: 0001209191-22-013725 · doc4.xml · nonDerivative · entry 3

LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,874

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.54, inclusive.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 22:55 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 53,800 $1.49 $80,162.00
Disclosure

SEC source: 0001209191-22-014998 · doc4.xml · nonDerivative · entry 1

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,303,506

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.43 to $1.70, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document
February 25, 2022 Filed Feb 28, 2022 17:26 UTC
Niihara YutakaDirector · Chairman and CEO · 10% owner
PurchaseCommon stock, $0.001 par value 5,500 $1.41 $7,755.00
Disclosure

SEC source: 0001209191-22-013475 · doc4.xml · nonDerivative · entry 2

Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,249,706

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.45, inclusive.

F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.